Loading clinical trials...
Loading clinical trials...
A Prospective Study for Evaluating the Safety and Performance of CSF-3 ECG Lead-I, HR and PR When Compared to ECG Holter
Conditions
Interventions
CSF-3 watch, designed to monitor a user's heart rate based on ECG (electrocardiogram) and PPG (Photoplethysmograph) readings
Locations
1
United States
Fairview Health Services
Minneapolis, Minnesota, United States
Start Date
November 16, 2022
Primary Completion Date
February 1, 2023
Completion Date
February 1, 2023
Last Updated
February 10, 2023
NCT06716502
NCT00090662
NCT07310264
NCT06290258
NCT07483606
NCT06342713
Lead Sponsor
CardiacSense Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions